老年男性下肢动脉硬化与骨密度的相关性研究(3)
 |
| 第1页 |
参见附件。
[5] Laroche M，Moulinier L，Leger P，et al. Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease[J]. Clin Exp Rheumatol，2003，21(1)：103-106.
[6] Tankó LB，Christiansen C，Cox DA，et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women[J]. J Bone Miner Res，2005，20(11)：1912-1920.
[7] Hofbauer LC，Heufelder AE. The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis[J]. Arthritis Rheum，2001，44(2)：253-259.
[8] 许勇，杨桦，乔建瓯，等. 骨保护素(opg)基因敲除小鼠发生高转换型骨质疏松和动脉钙化[J]. 生物化学与生物物理进展，2007，34(3)：260-266.
[9] Ovchinnikova O，Gylfe A，Bailey L，et al. Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice-brief report[J]. Arterioscler Thromb Vasc Biol，2009，29(10)：1478-1480.
[10] Min H，Morony S，Sarosi I，et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis[J]. J Exp Med，2000，192(4)：463-474.
[11] Brodeur MR，Brissette L，Falstrault L，et al. HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells：a protection against cell death[J]. J Cell Biochem，2008，105(6)：1374-1385.
[12] Kawaguchi H，Nemoto K，Raisz LG，et al. Interleukin-4 inhibits prostag-landin G/H synthase-2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures[J]. J Bone Miner Res，1996，11(3)：358-366.
[13] 罗南萍，李金花，王瑞山，等. IL-4、IL-6、IL-10及骨代谢指标与老年男性骨质疏松症的关系[J]. 中国老年学杂志，2004，24(1)：32-33.
[14] Parhami F，Garfinkel A，Demer LL. Role of lipids in osteoporosis[J]. Arterioscler Thromb Vasc Biol，2000，20(11):2346-2348.
(收稿日期：2011-08-16)
您现在查看是摘要介绍页，详见PDF附件(2981kb)。